Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Jiangsu Nhwa Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥26.7

2024-10-29

Market Capitalization

¥27 B

2024-10-29

Revenue

¥5.8 B

FY, 2025

CreditSafe Score

?
Score changed on Jul 20, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue3.8B4.1B3.3B3.9B4.2B4.9B5.6B5.8B
Cost of goods sold1.7B1.6B822.1M897.3M1.0B1.4B1.5B1.6B
Gross profit2.1B2.6B2.5B3.0B3.2B3.6B4.1B4.2B
Gross profit margin, %62.4%75.6%77.2%76.7%73.4%74.0%72.2%
Operating expense total1.4B1.7B1.6B2.0B2.2B2.4B2.7B2.9B
Depreciation and amortization78.0M86.2M95.0M106.5M121.1M133.0M149.3M167.6M
EBITDA678.5M797.3M899.1M996.1M1.0B1.2B1.4B1.3B
EBITDA margin, %19.5%27.3%25.8%24.8%25.3%25.6%22.3%
EBIT597.4M709.2M805.0M869.1M932.8M1.1B1.2B1.1B
EBIT margin, %17.4%24.4%22.5%22.2%22.4%21.8%18.9%
Interest income30.1M26.9M26.8M17.7M25.5M23.8M22.3M21.5M
Interest expense13.7M16.0M1.6M5.1M4.9M4.2M4.0M2.4M
Pre tax profit608.2M767.1M850.5M915.8M989.9M1.2B1.3B1.2B
Income tax expense89.0M110.0M123.4M117.8M109.5M134.4M155.9M118.2M
Net Income519.2M657.1M727.1M798.0M880.4M1.0B1.1B1.1B

Footer menu